Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Meta-Analysis
. 2020 Dec;22(12):1874-1884.
doi: 10.1111/codi.15148. Epub 2020 Jun 18.

Could FiLaC™ be effective in the treatment of anal fistulas? A systematic review of observational studies and proportional meta-analysis

M Frountzas  1   2 , K Stergios  1 , C Nikolaou  1 , I Bellos  1 , D Schizas  3 , D Linardoutsos  2 , K Kontzoglou  1 , G Vaos  4 , A B Williams  5 , K Toutouzas  2
Affiliations
Meta-Analysis

Could FiLaC™ be effective in the treatment of anal fistulas? A systematic review of observational studies and proportional meta-analysis

M Frountzas et al. Colorectal Dis. 2020 Dec.

Abstract

Aim: Fistula Laser Closure (FiLaC™) is a novel sphincter-preserving technique that is based on new technologies and shows promising results in repairing anal fistulas whilst maintaining external sphincter function. The aim of the present meta-analysis is to present the efficacy and the safety of FiLaC™ in the management of anal fistula disease.

Method: The present proportional meta-analysis was designed using the PRISMA and AMSTAR guidelines. We searched MEDLINE, Scopus, clinicaltrials.gov, Embase, Cochrane Central Register of Controlled Trials CENTRAL and Google Scholar databases from inception until November 2019.

Results: Overall, eight studies were included that recruited 476 patients. The pooled success rate of the technique was 63% (95% CI 50%-75%). The pooled complication rate was 8% (95% CI 1%-18%). Sixty-six per cent of patients had a transsphincteric fistula and 60% had undergone a previous surgical intervention, mainly the insertion of a seton (54%). The majority had a cryptoglandular fistula. Operation time and follow-up period were described for each study.

Conclusion: FiLaC™ seems to be an efficient therapeutic option for perianal fistula disease with an adequate level of safety that preserves quality of life. Nevertheless, randomized trials need to be designed to compare FiLaC™ with other procedures for the management of anal fistulas such as ligation of intersphincteric fistula tract, anal advancement flaps, fibrin glue, collagen paste, autologous adipose tissue, fistula plug and video-assisted anal fistula treatment.

Keywords: FiLaC™; anal; fistula; meta-analysis; treatment.

PubMed Disclaimer

References

    1. Sugrue J, Nordenstam J, Abcarian H et al. Pathogenesis and persistence of cryptoglandular anal fistula: a systematic review. Tech Coloproctol 2017; 21: 425-32.
    1. Owen HA, Buchanan GN, Schizas A, Cohen R, Williams AB. Quality of life with anal fistula. Ann Royal College Surg Engl 2016; 98: 334-8.
    1. Cadeddu F, Salis F, Lisi G, Ciangola I, Milito G. Complex anal fistula remains a challenge for colorectal surgeon. Int J Colorectal Dis 2015; 30: 595-603.
    1. Garcia-Olmo D, Van Assche G, Tagarro I et al. Prevalence of anal fistulas in Europe: systematic literature reviews and population-based database analysis. Adv Ther 2019; 36: 3503-18.
    1. Pommaret E, Benfredj P, Soudan D, de Parades V. Sphincter-sparing techniques for fistulas-in-ano. J Visc Surg 2015; 152(2 Suppl): S31-6.

LinkOut - more resources